Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot and disrupt the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. A small amount of the wart remover should then be applied using the provided applicator, ensuring that each wart is sufficiently covered.

This application should be allowed to dry, and the procedure may be repeated once or twice daily. Treatment can continue until the wart is removed, with a maximum duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product, except under the advice and supervision of a healthcare professional, such as a doctor or podiatrist, due to the increased risk of complications.

Application is contraindicated on irritated, infected, or reddened skin to prevent exacerbation of these conditions.

The product should not be applied to genital warts or warts located on the face, as these areas may require specialized treatment.

Use is also contraindicated on moles, birthmarks, and warts with hair growing from them to avoid potential adverse effects.

Additionally, the product must not be used on mucous membranes, as this may lead to irritation or other complications.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

This product should not be used by individuals who are diabetic or have poor blood circulation unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. Additionally, it is contraindicated for use on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. The product should not come into contact with mucous membranes.

While using this product, it is crucial to avoid contact with the eyes. In the event of contact, the eyes should be flushed with water for at least 15 minutes. Users should also take care to avoid inhaling vapors.

If discomfort persists, it is advised to discontinue use and consult a healthcare professional.

This product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should be aware that this product is intended for external use only. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. The product should not be applied to irritated, infected, or reddened skin, nor should it be used on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, it should not be applied to mucous membranes.

During the use of this product, patients are advised to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors associated with the product.

If discomfort persists, patients are instructed to stop using the product and consult a healthcare professional. It is important to keep this product out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should be advised against the use of this product if they have diabetes or poor blood circulation, unless under the guidance and supervision of a qualified healthcare professional, such as a doctor or podiatrist. The safety of this product during pregnancy has not been established, and it is classified for external use only. Healthcare providers should carefully consider the potential risks and benefits before recommending this product to pregnant patients, ensuring that appropriate precautions are taken to mitigate any potential adverse effects on fetal outcomes.

Lactation

There is no specific information available regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this product is not recommended for use in individuals with diabetes or poor blood circulation unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. It is also important to counsel patients against using the product on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. Additionally, patients should be cautioned not to apply the product to mucous membranes.

Healthcare providers should instruct patients to discontinue use and consult a doctor if discomfort persists. When using the product, patients must be advised to avoid contact with the eyes; if the product does get into the eyes, they should flush with water for 15 minutes. Furthermore, patients should be warned to avoid inhaling vapors while using the product to minimize respiratory irritation.

Storage and Handling

The product is supplied in a tightly capped bottle, which should be stored at room temperature, away from heat sources. It is essential to maintain the storage temperature between 20°C to 30°C (68°F to 86°F). Additionally, the product must be kept away from fire or flame to ensure safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)